Aviragen Therapeutics (AVIR) Misses Q4 EPS by 13c

Aviragen Therapeutics (NASDAQ: AVIR) reported Q4 EPS of ($0.57), $0.13 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Circle Internet Group sells $20.25M in ARC tokens to institutions
• Burry says he is short Micron